<DOC>
	<DOCNO>NCT01844297</DOCNO>
	<brief_summary>This study aim evaluate safety effectiveness tenofovir disoproxil fumarate ( TDF ) + lamivudine ( 3TC ) + efavirenz ( EFV ) regimen antiretroviral therapy ( ART ) -naive Chinese HIV/AIDS patient .</brief_summary>
	<brief_title>Efficacy Safety Tenofovir Plus Lamivudine Plus Efavirenz Regimen First-line Antiretroviral Therapy</brief_title>
	<detailed_description>This study prospective , open-label , multi-centered clinical trial ass virologic suppression immune recovery rate well tolerability regimen 3TC+TDF+EFV ARV-naive Chinese population . 500 eligible participant recruit take regimen If patient fails tolerate EFV , substitute NVP CD4 &lt; 250/μL , LPV/r CD4 &gt; 250/uL . If patient fails tolerate TDF , AZT alternative , except Hb &lt; 90/L neutrophil count &lt; 0.75×109/L . The participant follow month 0.5 , 1 , 2 ,3 every 3 month subsequently 2 year . The efficacy regimen evaluate comparison different point along time line previous regimen . The safety regimen assess monitor kidney function , bone density , cardiovascular profile , lipid profile , liver function etc well adverse event .</detailed_description>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>age 1865 year either gender HIV1 antibody seropositive detect ELISA confirm western blot CD4 cell count &lt; 500/ul Signed inform consent , condition precludes followup 2 year No plan move area trial antiretroviral therapy naive patient acute phase HIV infection patient ongoing opportunistic infection AIDSrelated malignancy ; opportunistic infection within previous 3 month still unstable within 14 day inclusion patient follow test result screen inclusion : WBC count &lt; 2000/ul , neutrophil count &lt; 1000/ul , Hb &lt; 9g/dl , platelet count &lt; 75000/ul , serum creatinine &gt; 1.5 ULN , transaminases alkaline phosphatase &gt; 3 ULN , total bilirubin &gt; 2 ULN , serum creatinine kinase &gt; 2 ULN CCr &lt; 60ml/min Pregnancy breastfeed Intravenous drug user Severe neuropathy mental disorder history alcohol abuse unable withdrawal Severe peptic ulcer disease NonChinese nationality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>